In analyses including matched groups (Table 2), patients with ≥67% of albumin-corrected serum calcium measurements outside, above, or below 2.00–2.25 mmol/L (8.0–9.0 mg/dL) had higher odds of developing CKD compared with patients with <33% of albumin-corrected serum calcium measurements. This evidence concerns the gene ALB and chronic kidney disease.